Lv2
130 积分 2025-12-08 加入
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
1个月前
已完结
Fructose: metabolic signal and modern hazard
2个月前
已完结
Monte Carlo Simulation for Trial Design Tool
4个月前
已完结
A Causal Mediation Approach to Account for Interaction of Treatment and Intercurrent Events: Using Hypothetical Strategy
5个月前
已完结
Stereotactic radioablation of ventricular arrhythmias in patients with structural heart disease - A systematic review
6个月前
已完结
A Causal Mediation Approach to Account for Interaction of Treatment and Intercurrent Events: Using Hypothetical Strategy
6个月前
已完结
Statistical Consideration for Fit-for-Use Real-World Data to Support Regulatory Decision Making in Drug Development
7个月前
已完结
皖公网安备34019202002308
